MX344705B - Composicion de aceite de hierbabuena de liberacion controlada en multiples particulas con recubrimienton enterico y metodo relacionados. - Google Patents
Composicion de aceite de hierbabuena de liberacion controlada en multiples particulas con recubrimienton enterico y metodo relacionados.Info
- Publication number
- MX344705B MX344705B MX2015005913A MX2015005913A MX344705B MX 344705 B MX344705 B MX 344705B MX 2015005913 A MX2015005913 A MX 2015005913A MX 2015005913 A MX2015005913 A MX 2015005913A MX 344705 B MX344705 B MX 344705B
- Authority
- MX
- Mexico
- Prior art keywords
- peppermint oil
- controlled release
- oil composition
- related methods
- enteric coated
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 title abstract 2
- 235000019477 peppermint oil Nutrition 0.000 title abstract 2
- 238000013270 controlled release Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 239000002702 enteric coating Substances 0.000 abstract 1
- 238000009505 enteric coating Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe una composición en múltiples partículas que se forma a partir de una pluralidad de núcleos individuales que incluyen una fase hidrofóbica que contiene el aceite de hierbabuena disperso en un gel a base de celulosa microcristalina y una fase hidrofílica que contiene un hidrogel. Un recubrimiento entérico está sobre los núcleos individuales. La composición en múltiples partículas puede usarse para tratar los trastornos gastrointestinales.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361815073P | 2013-04-23 | 2013-04-23 | |
US201361880294P | 2013-09-20 | 2013-09-20 | |
PCT/US2013/000217 WO2014175852A1 (en) | 2013-04-23 | 2013-09-23 | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015005913A MX2015005913A (es) | 2015-09-08 |
MX344705B true MX344705B (es) | 2017-01-04 |
Family
ID=51792243
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015014915A MX2015014915A (es) | 2013-04-23 | 2013-09-23 | Composicion multiparticulada con recubrimiento enterico que tiene un subrecubrimiento proteinico. |
MX2015005913A MX344705B (es) | 2013-04-23 | 2013-09-23 | Composicion de aceite de hierbabuena de liberacion controlada en multiples particulas con recubrimienton enterico y metodo relacionados. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015014915A MX2015014915A (es) | 2013-04-23 | 2013-09-23 | Composicion multiparticulada con recubrimiento enterico que tiene un subrecubrimiento proteinico. |
Country Status (21)
Country | Link |
---|---|
US (7) | US8895086B2 (es) |
EP (2) | EP2872123B1 (es) |
JP (3) | JP5869735B2 (es) |
KR (2) | KR101787225B1 (es) |
CN (2) | CN105142726B (es) |
AU (2) | AU2013387667B2 (es) |
BR (2) | BR112015026283B1 (es) |
CA (2) | CA2909591C (es) |
CY (1) | CY1121582T1 (es) |
DK (1) | DK2988824T3 (es) |
ES (2) | ES2706152T3 (es) |
HR (1) | HRP20190210T1 (es) |
HU (1) | HUE042996T2 (es) |
LT (1) | LT2988824T (es) |
MX (2) | MX2015014915A (es) |
PL (2) | PL2988824T3 (es) |
PT (2) | PT2872123T (es) |
RS (1) | RS58325B1 (es) |
RU (2) | RU2647462C2 (es) |
SI (1) | SI2988824T1 (es) |
WO (3) | WO2014175917A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
WO2012103411A2 (en) | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
IL312316A (en) | 2012-09-26 | 2024-06-01 | Aragon Pharmaceuticals Inc | Antiandrogens for the treatment of castration-resistant prostate cancer without metastases |
RU2647462C2 (ru) * | 2013-04-23 | 2018-03-15 | ЗедЭкс ФАРМА, ЭлЭлСи | Композиция, состоящая из множества частиц, покрытых кишечнорастворимой оболочкой и имеющих белковую внутреннюю оболочку |
PE20181295A1 (es) | 2015-09-01 | 2018-08-07 | First Wave Bio Inc | Metodos y composiciones para tratar afecciones asociadas a una respuesta inflamatoria anomala |
US10588864B2 (en) | 2016-03-11 | 2020-03-17 | Gateway Pharmaceuticals LLC | Pharmaceutical compositions for colon-specific delivery |
KR20190008265A (ko) | 2016-05-06 | 2019-01-23 | 피지션즈 씰, 엘엘씨 | 발레리안 조성물 및 관련 방법 |
KR102568459B1 (ko) | 2016-10-26 | 2023-08-22 | 에스엘 주식회사 | 차량용 램프 제어 장치 |
CN107049992A (zh) * | 2017-05-31 | 2017-08-18 | 盛林 | 一种egcg微丸胶囊及其制备方法 |
KR20200070334A (ko) | 2017-10-16 | 2020-06-17 | 아라곤 파마슈티컬스, 인코포레이티드 | 비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐 |
CN109864982A (zh) * | 2019-03-22 | 2019-06-11 | 大连医诺生物股份有限公司 | 表没食子儿茶素没食子酸酯微囊粉及其制备方法 |
JP2021003024A (ja) * | 2019-06-26 | 2021-01-14 | アリメント工業株式会社 | 徐放性被覆食品粉体集合体及びその製造方法 |
US20230102999A1 (en) | 2020-01-10 | 2023-03-30 | First Wave Bio, Inc. | Deuterated niclosamide |
US10980756B1 (en) | 2020-03-16 | 2021-04-20 | First Wave Bio, Inc. | Methods of treatment |
US20230190684A1 (en) | 2020-03-16 | 2023-06-22 | First Wave Bio, Inc. | Methods of treating covid-19 with a niclosamide compound |
KR102608047B1 (ko) * | 2020-12-29 | 2023-12-01 | 주식회사 우제아이엠 | 역류성 식도질환 또는 기능성 소화불량의 예방 또는 개선을 위한 균형영양식품 조성물 |
WO2022148672A1 (en) * | 2021-01-08 | 2022-07-14 | Société des Produits Nestlé S.A. | Oral solid cannabinoid oil composition for treating central nervous system disorders |
Family Cites Families (126)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1811777A (en) | 1924-06-19 | 1931-06-23 | Howards & Sons Ltd | Process for making synthetic menthol |
US2366749A (en) | 1942-08-29 | 1945-01-09 | Burton T Bush Inc | Process for making synthetic menthol |
US3515781A (en) | 1967-10-12 | 1970-06-02 | Johnson & Johnson | Cold capsule |
JPS521819A (en) | 1975-06-05 | 1977-01-08 | Nippon Tokushu Toryo Kk | Acoustic lining material for vehicle |
US4080552A (en) | 1976-09-22 | 1978-03-21 | Facet Enterprises, Inc. | Hybrid blocking oscillator for an electromagnetic fuel pump |
EP0015334B1 (en) | 1977-08-04 | 1982-05-19 | J.B. Tillott Limited | Carminative preparations containing peppermint oil or its active components |
JPS61176535A (ja) * | 1985-01-31 | 1986-08-08 | Morishita Jintan Kk | 腸溶性製剤 |
JPS62226926A (ja) * | 1986-03-27 | 1987-10-05 | Teisan Seiyaku Kk | 持続性複合顆粒剤 |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US4808413A (en) | 1987-04-28 | 1989-02-28 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions in the form of beadlets and method |
IT1243193B (it) | 1990-08-10 | 1994-05-24 | Medea Res Srl | Composizioni farmaceutiche orali a base di melatonina |
US5418010A (en) * | 1990-10-05 | 1995-05-23 | Griffith Laboratories Worldwide, Inc. | Microencapsulation process |
US5169754A (en) * | 1990-10-31 | 1992-12-08 | Coulter Corporation | Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same |
DE122007000073I1 (de) | 1991-05-09 | 2008-01-31 | Neurim Pharma 1991 | Melatonin enthaltene Arzneimittel |
JP3015607B2 (ja) | 1991-10-16 | 2000-03-06 | 信越化学工業株式会社 | フェロモン製剤を用いた交信撹乱方法 |
US7070806B2 (en) | 1992-01-27 | 2006-07-04 | Purdue Pharma Lp | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5397573A (en) | 1993-06-04 | 1995-03-14 | The Procter & Gamble Company | Laxative compositions |
US5417010A (en) * | 1993-08-09 | 1995-05-23 | Ecer; Gunes M. | Light weight seeding sheet |
US5688510A (en) | 1993-11-18 | 1997-11-18 | Nippon Shinyaku Co. Ltd. | Process for producing stable medicinal composition, and pharmaceutical preparation |
US6469044B1 (en) | 1995-02-01 | 2002-10-22 | Neurim Pharmaceuticals (1991) Ltd. | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
US5840332A (en) | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
AU7375598A (en) | 1997-05-09 | 1998-11-27 | Sage Pharmaceuticals, Inc. | Stable oral pharmaceutical dosage forms |
JPH1147581A (ja) | 1997-07-30 | 1999-02-23 | Takasago Internatl Corp | 徐放性カプセル及びその製造方法 |
FR2771292B1 (fr) | 1997-11-21 | 2000-02-18 | Ethypharm Lab Prod Ethiques | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
US6365185B1 (en) | 1998-03-26 | 2002-04-02 | University Of Cincinnati | Self-destructing, controlled release peroral drug delivery system |
US6673126B2 (en) | 1998-05-14 | 2004-01-06 | Seiko Epson Corporation | Multiple chamber fabrication equipment for thin film transistors in a display or electronic device |
US6328994B1 (en) | 1998-05-18 | 2001-12-11 | Takeda Chemical Industries, Ltd. | Orally disintegrable tablets |
US6602521B1 (en) | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
US6531152B1 (en) | 1998-09-30 | 2003-03-11 | Dexcel Pharma Technologies Ltd. | Immediate release gastrointestinal drug delivery system |
JP2000247870A (ja) | 1999-02-24 | 2000-09-12 | Isp Japan Kk | ウィスカー析出が抑制された固形状製剤及びその製造方法 |
US8545880B2 (en) | 1999-02-26 | 2013-10-01 | Andrx Pharmaceuticals, Llc | Controlled release oral dosage form |
US6632451B2 (en) | 1999-06-04 | 2003-10-14 | Dexcel Pharma Technologies Ltd. | Delayed total release two pulse gastrointestinal drug delivery system |
EP1184038B1 (en) | 1999-06-09 | 2005-12-28 | Mochida Pharmaceutical Co., Ltd. | System for release in lower digestive tract |
NZ517465A (en) | 1999-09-02 | 2003-10-31 | Nostrum Pharmaceuticals Inc | Controlled release pellet formulation |
US6627223B2 (en) | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
US6458384B2 (en) | 2000-02-23 | 2002-10-01 | Impetus Ag | Pharmaceutical with predetermined activity profile |
ES2253147T3 (es) | 2000-03-04 | 2006-06-01 | Cognis Ip Management Gmbh | Microcapsulas. |
US6306435B1 (en) | 2000-06-26 | 2001-10-23 | Yung Shin Pharmaceutical Industrial Co. Ltd. | Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same |
US6423349B1 (en) | 2000-08-24 | 2002-07-23 | Baxter International, Inc. | Therapeutic nutrient composition for pre and post elective surgery |
GB0025208D0 (en) | 2000-10-13 | 2000-11-29 | Euro Celtique Sa | Delayed release pharmaceutical formulations |
FR2816507B1 (fr) | 2000-11-16 | 2003-02-28 | Ethypharm Lab Prod Ethiques | Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules |
US20020114832A1 (en) | 2000-12-11 | 2002-08-22 | Dr. Willmar Schwabe Gmbh & Co. | Pharmaceutical preparation comprising peppermint oil and caraway oil in delayed release form |
US20030143272A1 (en) | 2001-03-14 | 2003-07-31 | Waterman Kenneth C. | Pharmaceutical tablet and process for making thereof |
ATE487472T1 (de) | 2001-11-22 | 2010-11-15 | Morishita Jintan Co | Nicht-gelatinöse kapseln |
US20030232839A1 (en) | 2002-01-18 | 2003-12-18 | Hypnion, Inc. | Treatment of sleeping disorders using CNS sleep target modulators |
JP4429590B2 (ja) * | 2002-02-08 | 2010-03-10 | 株式会社協和ウェルネス | ユビキノン含有水可溶性組成物 |
AU2003220551A1 (en) | 2002-03-26 | 2003-10-13 | Euro-Celtique S.A. | Sustained-release gel coated compositions |
US7115282B2 (en) | 2002-04-17 | 2006-10-03 | Salvona Ip Llc | Multi component controlled release system for anhydrous cosmetic compositions |
US6919348B2 (en) | 2002-05-02 | 2005-07-19 | Edward T. Wei | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
DE10224087A1 (de) | 2002-05-31 | 2003-12-11 | Symrise Gmbh & Co Kg | Kompaktiertes Menthol |
US20040062778A1 (en) | 2002-09-26 | 2004-04-01 | Adi Shefer | Surface dissolution and/or bulk erosion controlled release compositions and devices |
DK1545475T3 (da) * | 2002-10-01 | 2014-07-28 | Banner Pharmacaps Inc | Enterisk sammensætning til fremstillingen af blød kapselvæg |
FR2845289B1 (fr) | 2002-10-04 | 2004-12-03 | Ethypharm Sa | Spheroides, procede de preparation et compositions pharmaceutiques. |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
AU2003274355A1 (en) | 2002-10-24 | 2004-05-13 | Micap Plc. | Targeted delivery |
EP1556021B1 (en) * | 2002-10-24 | 2007-12-19 | Immupharm A/S | Pharmaceutical compositions comprising flavonoids and menthol |
WO2004086874A1 (en) | 2003-03-26 | 2004-10-14 | Wm. Wrigley Jr. Company | Confectionery with fast flavor release jacket coating |
US6737470B1 (en) | 2003-04-04 | 2004-05-18 | Bridgestone Corporation | Curable sealant composition |
EP1670442A4 (en) * | 2003-09-19 | 2011-09-14 | Penwest Pharmaceuticals Co | DOSAGE FORMS WITH DELAYED RELEASE |
TWI372066B (en) | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
US20050164987A1 (en) | 2003-12-24 | 2005-07-28 | Barberich Timothy J. | Melatonin combination therapy for improving sleep quality |
US7670624B2 (en) | 2004-01-29 | 2010-03-02 | Astella Pharma Inc. | Gastrointestinal-specific multiple drug release system |
US20050181047A1 (en) | 2004-02-18 | 2005-08-18 | Jaime Romero | Compositions and methods for timed release of water-soluble nutritional supplements |
US20050202079A1 (en) | 2004-03-15 | 2005-09-15 | Mylan Pharmaceuticals Inc. | Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation |
PL1746980T3 (pl) * | 2004-05-07 | 2012-03-30 | Nycomed Gmbh | Farmaceutyczna postać dawkowania zawierająca peletki i sposób jej wytwarzania |
US8383154B2 (en) | 2004-05-11 | 2013-02-26 | Egalet A/S | Swellable dosage form comprising gellan gum |
US20050281876A1 (en) | 2004-06-18 | 2005-12-22 | Shun-Por Li | Solid dosage form for acid-labile active ingredient |
DE102004036437A1 (de) | 2004-07-27 | 2006-03-23 | Röhm GmbH & Co. KG | Multipartikuläre Arzneiform für wenig lösliche Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform |
ITMI20041689A1 (it) | 2004-09-01 | 2004-12-02 | Bojidar Mihaylov Stankov | Nuove formulazioni di rilascio controllato contenenti 5-idrossitriptofano e triptofano |
KR20070084325A (ko) * | 2004-11-18 | 2007-08-24 | 브리스톨-마이어스 스큅 컴퍼니 | 익사베필론을 포함하는 장용성 코팅된 비드 및 그의 제조방법 |
US8574544B1 (en) | 2005-01-04 | 2013-11-05 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
US8361439B1 (en) | 2005-01-04 | 2013-01-29 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
US8535640B1 (en) | 2005-01-04 | 2013-09-17 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
US8337811B1 (en) | 2005-01-04 | 2012-12-25 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
JP5282208B2 (ja) | 2005-03-16 | 2013-09-04 | シムライズ アーゲー | メントール含有固体組成物 |
US9149439B2 (en) * | 2005-03-21 | 2015-10-06 | Sandoz Ag | Multi-particulate, modified-release composition |
CN101111231A (zh) | 2005-03-29 | 2008-01-23 | 罗姆有限公司 | 包含具有影响调节物质递送的基质的小丸的多颗粒药用形式 |
US20060257469A1 (en) | 2005-04-05 | 2006-11-16 | Bulka Yochanan R | Enhanced indoleamine and catecholamine bio-availability via catechin inhibition of L-Dopa decarboxylase |
EP1875911A4 (en) * | 2005-04-28 | 2010-03-03 | Eisai R&D Man Co Ltd | STABILIZED COMPOSITION |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
US20060280795A1 (en) | 2005-06-08 | 2006-12-14 | Dexcel Pharma Technologies, Ltd. | Specific time-delayed burst profile delivery system |
AU2006273842B2 (en) | 2005-07-28 | 2012-02-02 | University Of Hull | Topical formulations containing sporopollenin |
US20070048366A1 (en) | 2005-08-26 | 2007-03-01 | Jen-Chi Chen | Gelatin-based coatings having improved durability |
JP2007197378A (ja) | 2006-01-27 | 2007-08-09 | Kowa Co | 糖衣製剤 |
US20070292510A1 (en) * | 2006-06-19 | 2007-12-20 | Hugh Huang | Enteric coated particles containing an active ingredient |
WO2008057802A2 (en) * | 2006-10-27 | 2008-05-15 | The Curators Of The University Of Missouri | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
JP5201819B2 (ja) | 2006-11-22 | 2013-06-05 | エスエス製薬株式会社 | 固形組成物 |
AR063983A1 (es) | 2006-11-28 | 2009-03-04 | Wyeth Corp | Formulacion de liberacion controlada de agonistas y antagonistas de piperazina -piperidina del receptor 5-ht1a que tienen una disolucion intestinal mejorada |
JP2010510988A (ja) * | 2006-11-28 | 2010-04-08 | マリナス ファーマシューティカルズ | ナノ粒子製剤とその製造方法およびその利用 |
US20080139510A1 (en) | 2006-12-07 | 2008-06-12 | Abe Rose | Treatment of migraine headaches with sublingual amino acids |
EP1953625A1 (en) | 2007-02-02 | 2008-08-06 | Melik Gencel | Peripheral inputting device for computers |
ES2575549T3 (es) | 2007-04-11 | 2016-06-29 | John A. Mccarty | Comprimido de melatonina y métodos de preparación y uso |
WO2008134807A1 (en) | 2007-05-04 | 2008-11-13 | The University Of Sydney | Method for manufacturing a porous polymer matrix |
US20090004281A1 (en) * | 2007-06-26 | 2009-01-01 | Biovail Laboratories International S.R.L. | Multiparticulate osmotic delivery system |
US20100261723A1 (en) | 2007-07-09 | 2010-10-14 | Astrazeneca Ab | Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
US8048921B2 (en) | 2007-09-18 | 2011-11-01 | Ronald Kramer | Amino acid compounds |
EP2205231A1 (en) | 2007-10-01 | 2010-07-14 | NeuroSearch A/S | Pharmaceutical compositions of 5-hydr0xytrypt0phan and serotonin-enhancing compound |
GB0724550D0 (en) * | 2007-12-18 | 2008-01-30 | Univ Hull | Formulations |
US20090238905A1 (en) | 2008-03-20 | 2009-09-24 | Symrise, Inc. | Inflammation reducing action of synergistic mixtures of bisabolol and ginger extracts |
US20090246301A1 (en) * | 2008-03-31 | 2009-10-01 | Ehrenpreis Ben Z | Method for treating irritable bowel syndrome and other functional gastrointestinal disorders |
DE102008023345B4 (de) | 2008-05-13 | 2014-12-04 | Lts Lohmann Therapie-Systeme Ag | Filmförmige Zubereitung mit öligen Substanzen zur oralen Verabreichung |
CN101596166B (zh) | 2008-06-04 | 2011-08-17 | 永信药品工业(昆山)有限公司 | 阿司匹林肠溶微丸 |
AU2009258120B2 (en) * | 2008-06-10 | 2014-11-27 | Teva Pharmaceutical Industries, Ltd. | Rasagiline soft gelatin capsules |
US20110053866A1 (en) | 2008-08-12 | 2011-03-03 | Biovail Laboratories International (Barbados) S.R.L. | Pharmaceutical compositions |
US20120128764A1 (en) * | 2009-02-23 | 2012-05-24 | Aptalis Pharmatech, Inc. | Controlled-release compositions comprising a proton pump inhibitor |
EP2437730A4 (en) | 2009-05-20 | 2014-02-26 | Lingual Consegna Pty Ltd | ORAL AND / OR SUBLINGUAL THERAPEUTIC FORMULATION |
EP2305742B1 (en) | 2009-10-01 | 2017-02-22 | Symrise AG | Spherical core-shell-particle |
US9205395B2 (en) | 2009-10-15 | 2015-12-08 | Encapsys, Llc | Encapsulation |
WO2011057206A1 (en) * | 2009-11-07 | 2011-05-12 | University Of Iowa Research Foundation | Cellulose capsules and methods for making them |
WO2011111027A2 (en) | 2010-03-11 | 2011-09-15 | Dexcel Pharma Technologies Ltd. | Oral dispersible delayed release tablet formulation |
WO2011146078A1 (en) | 2010-05-21 | 2011-11-24 | Board Of Regents, The University Of Texas System | Encapsulated particles for enteric release |
JP2010189443A (ja) | 2010-06-07 | 2010-09-02 | Ss Pharmaceut Co Ltd | 揮散防止型固形製剤およびその製造方法 |
CN103826614B (zh) | 2010-11-16 | 2018-04-13 | 普乐维美北美公司 | 用于呕吐毒素解毒的包肠溶衣的焦亚硫酸钠禽畜饲料添加剂 |
BE1019142A3 (fr) * | 2011-01-21 | 2012-03-06 | Vesale Pharma S A | Substance probiotique microencapsulee. |
US8568776B2 (en) * | 2011-02-11 | 2013-10-29 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
US20120301541A1 (en) | 2011-05-24 | 2012-11-29 | Haronsky Elina | Compressed core for pharmaceutical composition |
US20120301546A1 (en) * | 2011-05-26 | 2012-11-29 | Hassan Emadeldin M | Acid-resistant soft gel compositions |
US20120315337A1 (en) | 2011-06-07 | 2012-12-13 | Shah Syed | Multiparticulate 5-htp compositions and related methods |
WO2012170488A1 (en) | 2011-06-07 | 2012-12-13 | Zx Pharma, Llc | Multiparticulate s-adenosylmethionine compositions and related methods |
DE202012000910U1 (de) * | 2012-01-20 | 2013-01-21 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Systemische Darreichungsformen mit kontrollierter Freisetzung und verbesserter Stabilität |
JP6227546B2 (ja) | 2012-10-26 | 2017-11-08 | 田辺三菱製薬株式会社 | メントールウィスカーの析出を抑制する方法 |
US20140178468A1 (en) | 2012-12-24 | 2014-06-26 | Ranbaxy Laboratories Limited | Multiparticulate extended-release composition of mesalamine |
RU2647462C2 (ru) * | 2013-04-23 | 2018-03-15 | ЗедЭкс ФАРМА, ЭлЭлСи | Композиция, состоящая из множества частиц, покрытых кишечнорастворимой оболочкой и имеющих белковую внутреннюю оболочку |
JP2015024986A (ja) | 2013-06-20 | 2015-02-05 | 大正製薬株式会社 | 固形製剤 |
-
2013
- 2013-09-23 RU RU2015149770A patent/RU2647462C2/ru active
- 2013-09-23 WO PCT/US2013/061146 patent/WO2014175917A1/en active Application Filing
- 2013-09-23 ES ES13882940T patent/ES2706152T3/es active Active
- 2013-09-23 LT LTEP13882940.3T patent/LT2988824T/lt unknown
- 2013-09-23 KR KR1020157032077A patent/KR101787225B1/ko active IP Right Grant
- 2013-09-23 WO PCT/US2013/061141 patent/WO2014175916A1/en active Application Filing
- 2013-09-23 CA CA2909591A patent/CA2909591C/en active Active
- 2013-09-23 WO PCT/US2013/000217 patent/WO2014175852A1/en active Application Filing
- 2013-09-23 RU RU2015136984A patent/RU2606593C1/ru active
- 2013-09-23 PL PL13882940T patent/PL2988824T3/pl unknown
- 2013-09-23 EP EP13883071.6A patent/EP2872123B1/en active Active
- 2013-09-23 AU AU2013387667A patent/AU2013387667B2/en active Active
- 2013-09-23 JP JP2015536756A patent/JP5869735B2/ja active Active
- 2013-09-23 CN CN201380075897.8A patent/CN105142726B/zh active Active
- 2013-09-23 RS RS20190090A patent/RS58325B1/sr unknown
- 2013-09-23 DK DK13882940.3T patent/DK2988824T3/en active
- 2013-09-23 KR KR1020157005776A patent/KR101616679B1/ko active IP Right Grant
- 2013-09-23 CA CA2881992A patent/CA2881992C/en active Active
- 2013-09-23 SI SI201331292T patent/SI2988824T1/sl unknown
- 2013-09-23 AU AU2013387678A patent/AU2013387678B2/en active Active
- 2013-09-23 MX MX2015014915A patent/MX2015014915A/es active IP Right Grant
- 2013-09-23 MX MX2015005913A patent/MX344705B/es active IP Right Grant
- 2013-09-23 EP EP13882940.3A patent/EP2988824B1/en active Active
- 2013-09-23 BR BR112015026283-0A patent/BR112015026283B1/pt active IP Right Grant
- 2013-09-23 US US14/033,713 patent/US8895086B2/en not_active Expired - Fee Related
- 2013-09-23 HU HUE13882940A patent/HUE042996T2/hu unknown
- 2013-09-23 JP JP2016510666A patent/JP2016517867A/ja active Pending
- 2013-09-23 PT PT138830716T patent/PT2872123T/pt unknown
- 2013-09-23 PT PT13882940T patent/PT2988824T/pt unknown
- 2013-09-23 CN CN201380052353.XA patent/CN105263480B/zh active Active
- 2013-09-23 PL PL13883071T patent/PL2872123T3/pl unknown
- 2013-09-23 ES ES13883071.6T patent/ES2616701T3/es active Active
- 2013-09-23 BR BR112015006499A patent/BR112015006499A2/pt not_active Application Discontinuation
-
2014
- 2014-10-27 US US14/524,326 patent/US9192583B2/en active Active
- 2014-10-27 US US14/524,648 patent/US9572782B2/en active Active
-
2015
- 2015-10-06 US US14/876,465 patent/US10420730B2/en active Active
- 2015-10-20 US US14/918,042 patent/US9717696B2/en active Active
-
2016
- 2016-01-07 JP JP2016001544A patent/JP6105761B2/ja active Active
-
2019
- 2019-01-07 CY CY20191100012T patent/CY1121582T1/el unknown
- 2019-01-31 HR HRP20190210TT patent/HRP20190210T1/hr unknown
- 2019-06-21 US US16/448,284 patent/US11207273B2/en active Active
-
2021
- 2021-11-17 US US17/528,689 patent/US11826475B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015005913A (es) | Composicion de aceite de hierbabuena de liberacion controlada en multiples particulas con recubrimienton enterico y metodo relacionados. | |
FR22C1013I2 (fr) | Dihydronaphtyridines et composés apparentés utiles comme inhibiteurs de kinases pour le traitement de maladies prolifératives | |
EP3405251A4 (en) | SYSTEMS, METHODS AND DEVICES FOR PERIPHERAL NEUROMODULATION FOR THE TREATMENT OF DISEASES RELATED TO BUBBLE HYPERACTIVITY | |
EP3488406A4 (en) | METHOD OF DISTRIBUTING TOKENS AND MANAGING TOKEN RELATIONS | |
EP3091674A4 (en) | Method and mtc device for performing random access procedure according to plurality of parameter sets | |
EP2986047A4 (en) | METHOD AND DEVICE FOR DYNAMICALLY ALLOCATING SPECTRA | |
SG11201602421VA (en) | Inhibitors of bruton's tyrosine kinase | |
EP4324527A3 (en) | Formulations of enzalutamide | |
EP3019489A4 (en) | MODULATORS OF TYROSINE KINASE PROTEIN AND METHODS OF USE | |
EP3282781A4 (en) | Method and device for improving positioning performance of artificial neural network | |
EP2971004A4 (en) | PROCESS FOR MODULATING PLANT SEA AND NECTAR CONTENT | |
HK1217896A1 (zh) | 用於治療廣泛性發展障礙的複合物及方法 | |
IL267405B (en) | Coated nanoparticles for use in modulation of electrical polarization of neurons | |
EP3038634A4 (en) | Novel sez6 modulators and methods of use | |
PT3280392T (pt) | Regimes de dosagem de amissulprida para tratamento de náuseas e vómitos | |
EP3027147A4 (en) | ARTIFICIAL DISC DEVICE AND RELATED METHODS OF USE | |
EP3039022A4 (en) | Compositions and methods for the treatment of metabolic and body weight related disorders | |
EP2899262A4 (en) | PREPARATION AND USE OF A NEURONAL NETWORK AND NEURONIC PLANTING DEVICE | |
EP2970223A4 (en) | Novel Modulators of 5-Hydroxypropylamine Receptor 7 Activity and Methods of Use | |
EP3200589A4 (en) | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use | |
EP3469601A4 (en) | HYBRID POLYMER-SILICA PDOTS AND METHOD FOR USE THEREOF | |
EP3071350A4 (en) | Coated casting cores and manufacture methods | |
GB2538031A (en) | Methods of producing particles having two different properties | |
EP3367536A4 (en) | METHOD AND DEVICE FOR ASSIGNING THE EFFICIENCY OF A WIND ENERGY SYSTEM | |
EP3415864A4 (en) | SHAPE MEASURING DEVICE AND METHOD FOR MANUFACTURING AN OBJECT TO BE COATED |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |